WallStreetZenWallStreetZen

NYSE: TARO
Taro Pharmaceutical Industries Ltd Stock Forecast, Predictions & Price Target

Analyst price target for TARO

Based on 1 analyst offering 12 month price targets for Taro Pharmaceutical Industries Ltd.
Min Forecast
$43.00+1.56%
Avg Forecast
$43.00+1.56%
Max Forecast
$43.00+1.56%

Should I buy or sell TARO stock?

Based on 1 analyst offering ratings for Taro Pharmaceutical Industries Ltd.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TARO stock forecasts and price targets.

TARO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-18

1 of 1

Forecast return on equity

Is TARO forecast to generate an efficient return?

Forecast return on assets

Is TARO forecast to generate an efficient return on assets?

TARO revenue forecast

What is TARO's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$618.1M+1.19%

TARO vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TARO$42.34$43.00+1.56%Hold
DVAX$12.41$25.00+101.45%Buy
AVDL$16.89$23.67+40.12%Strong Buy
ANIP$69.13$80.00+15.72%Strong Buy
IRWD$8.71$18.67+114.32%Strong Buy

Taro Pharmaceutical Industries Stock Forecast FAQ

Is Taro Pharmaceutical Industries Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: TARO) stock is to Hold TARO stock.

Out of 1 analyst, 0 (0%) are recommending TARO as a Strong Buy, 0 (0%) are recommending TARO as a Buy, 1 (100%) are recommending TARO as a Hold, 0 (0%) are recommending TARO as a Sell, and 0 (0%) are recommending TARO as a Strong Sell.

If you're new to stock investing, here's how to buy Taro Pharmaceutical Industries stock.

What is TARO's revenue growth forecast for 2024-2024?

(NYSE: TARO) Taro Pharmaceutical Industries's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Taro Pharmaceutical Industries's revenue in 2024 is $610,828,000.

In 2024, TARO is forecast to generate $23,232,667,481 in revenue, with the lowest revenue forecast at $23,232,667,481 and the highest revenue forecast at $23,232,667,481.

What is TARO's forecast return on assets (ROA) for 2024-2024?

(NYSE: TARO) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 9.86%.

What is TARO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TARO price target, the average TARO price target is $43.00, with the highest TARO stock price forecast at $43.00 and the lowest TARO stock price forecast at $43.00.

The Wall Street analyst predicted that Taro Pharmaceutical Industries's share price could reach $43.00 by Jan 18, 2025. The average Taro Pharmaceutical Industries stock price prediction forecasts a potential upside of 1.56% from the current TARO share price of $42.34.

What is TARO's forecast return on equity (ROE) for 2024-2024?

(NYSE: TARO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.